Chen Y, Leon-Letelier R, Sater A, Vykoukal J, Dennison J, Hanash S
Cancers (Basel). 2023; 15(3).
PMID: 36765581
PMC: 9913358.
DOI: 10.3390/cancers15030623.
Reyes-Gonzalez J, Vivas-Mejia P
Front Oncol. 2021; 11:601512.
PMID: 33718147
PMC: 7952744.
DOI: 10.3389/fonc.2021.601512.
Davis T
Proc Natl Acad Sci U S A. 2020; 117(2):796-798.
PMID: 31888982
PMC: 6969533.
DOI: 10.1073/pnas.1921332117.
Williams C
J Clin Invest. 2019; 129(10):3963-3965.
PMID: 31499488
PMC: 6763264.
DOI: 10.1172/JCI132533.
Albanese C, Suttapitugsakul S, Perati S, McGown L
Talanta. 2017; 177:150-156.
PMID: 29108569
PMC: 5679784.
DOI: 10.1016/j.talanta.2017.08.093.
Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M, Helma R, Polaskova A, Krejci A, Dvorakova Z, Kejnovska I
Biosci Rep. 2016; 36(5).
PMID: 27634752
PMC: 5064454.
DOI: 10.1042/BSR20160232.
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.
Catenacci D, Liao W, Zhao L, Whitcomb E, Henderson L, ODay E
Gastric Cancer. 2015; 19(4):1066-1079.
PMID: 26581548
PMC: 4871781.
DOI: 10.1007/s10120-015-0566-0.
Unraveling the association between mRNA expressions and mutant phenotypes in a genome-wide assessment of mice.
Liao B, Weng M
Proc Natl Acad Sci U S A. 2015; 112(15):4707-12.
PMID: 25825715
PMC: 4403156.
DOI: 10.1073/pnas.1415046112.
Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity.
Catenacci D
Mol Oncol. 2015; 9(5):967-96.
PMID: 25557400
PMC: 4402102.
DOI: 10.1016/j.molonc.2014.09.011.
Genetically engineered mice as experimental tools to dissect the critical events in breast cancer.
Menezes M, Das S, Emdad L, Windle J, Wang X, Sarkar D
Adv Cancer Res. 2014; 121:331-382.
PMID: 24889535
PMC: 4349377.
DOI: 10.1016/B978-0-12-800249-0.00008-1.
Demography and histologic pattern of laryngeal squamous cell carcinoma in kenya.
Menach O, Patel A, Oburra H
Int J Otolaryngol. 2014; 2014:507189.
PMID: 24672554
PMC: 3941967.
DOI: 10.1155/2014/507189.
The effect of molecular crowding on the stability of human c-MYC promoter sequence I-motif at neutral pH.
Cui J, Waltman P, Le V, Lewis E
Molecules. 2013; 18(10):12751-67.
PMID: 24132198
PMC: 6270392.
DOI: 10.3390/molecules181012751.
Existence of G-quadruplex structures in promoter region of oncogenes confirmed by G-quadruplex DNA cross-linking strategy.
Yuan L, Tian T, Chen Y, Yan S, Xing X, Zhang Z
Sci Rep. 2013; 3:1811.
PMID: 23657205
PMC: 3648798.
DOI: 10.1038/srep01811.
Significance of Her-2/neu protein over expression in Indian breast cancer patients.
Kumar V, Tewari M, Singh U, Shukla H
Indian J Surg. 2012; 69(4):122-8.
PMID: 23132963
PMC: 3452466.
DOI: 10.1007/s12262-007-0002-8.
Unbalanced replication as a major source of genetic instability in cancer cells.
Corcos D
Am J Blood Res. 2012; 2(3):160-9.
PMID: 23119227
PMC: 3484411.
Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
Boddupally P, Hahn S, Beman C, De B, Brooks T, Gokhale V
J Med Chem. 2012; 55(13):6076-86.
PMID: 22691117
PMC: 3395776.
DOI: 10.1021/jm300282c.
Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.
Brown R, Danford F, Gokhale V, Hurley L, Brooks T
J Biol Chem. 2011; 286(47):41018-27.
PMID: 21956115
PMC: 3220475.
DOI: 10.1074/jbc.M111.274720.
Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein.
Gonzalez V, Guo K, Hurley L, Sun D
J Biol Chem. 2009; 284(35):23622-35.
PMID: 19581307
PMC: 2749137.
DOI: 10.1074/jbc.M109.018028.
Molecular modeling and biophysical analysis of the c-MYC NHE-III1 silencer element.
Cashman D, Buscaglia R, Freyer M, Dettler J, Hurley L, Lewis E
J Mol Model. 2007; 14(2):93-101.
PMID: 18087730
DOI: 10.1007/s00894-007-0254-z.
Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics.
Patel D, Phan A, Kuryavyi V
Nucleic Acids Res. 2007; 35(22):7429-55.
PMID: 17913750
PMC: 2190718.
DOI: 10.1093/nar/gkm711.